Kodiak Sciences Inc. KOD
Set alert
At close · Oct 30
After hours · Oct 30, 6:32 PM ET
- YTD
- +254.72%
- 1 year
- +371.16%
- Open
- 99.41
- Prev close
- 100.40
- Mkt cap
- 6.23B
- Vol
- 568.10K
- Avg vol
- 1.71M
- EPS
- -4.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 96.58
- High
- 100.69
- Forward P/E
- -28.87
- Beta
- 2.04
- Short ratio
- 2.38
- Inst. own
- 105.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 62.54
- 200-d avg
- 41.74
- 1y target
- 121.67
MAX chart
Events in this range
- Feb 23, 2022Split: 5 for 1
- Aug 13, 2025Earnings: -1.03; estimate -1.01; surprise -1.98%
- Nov 13, 2025Earnings: -1.16; estimate -1.07; surprise -8.41%
- Mar 31, 2026Earnings: -1.04; estimate -1.02; surprise -1.96%
- May 7, 2026Earnings: -0.94; estimate -0.93; surprise -1.08%
- Aug 12, 2026Earnings: -1.05; estimate -0.95647; surprise -9.78%
- Aug 17, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Sep 17, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Sep 28, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Sep 28, 2026Rating: UBS · Buy → Buy
- Sep 28, 2026Rating: LifeSci Capital · Outperform → Outperform
- Oct 12, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (116)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| MACD: Buy Signal | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| RSI: Overbought | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| RSI: Overbought | Jan 5, 2026 | 9 months ago |
| RSI: Overbought | Nov 10, 2025 | 11 months ago |
| RSI: Overbought | Oct 20, 2025 | 1 year ago |
| RSI: Overbought | Sep 22, 2025 | 1 year ago |
| RSI: Overbought | Aug 11, 2025 | 1 year ago |
| RSI: Overbought | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 13, 2025 | 1 year ago |
| RSI: Overbought | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Sep 23, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| SMA: Bearish | May 6, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 15, 2024 | 2 years ago |
| SMA: Bearish | Mar 25, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 30, 2023 | 3 years ago |
| RSI: Oversold | Oct 23, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 24, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | May 29, 2023 | 3 years ago |
| SMA: Bullish | May 15, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 30, 2023 | 3 years ago |
| SMA: Bearish | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bullish | Nov 14, 2022 | 3 years ago |
| RSI: Oversold | Oct 10, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bullish | May 16, 2022 | 4 years ago |
| MACD: Buy Signal | May 16, 2022 | 4 years ago |
| RSI: Oversold | Feb 21, 2022 | 4 years ago |
| MACD: Sell Signal | Nov 29, 2021 | 4 years ago |
| SMA: Bearish | Nov 22, 2021 | 4 years ago |
| SMA: Bearish | Nov 15, 2021 | 4 years ago |
| SMA: Bullish | Oct 4, 2021 | 5 years ago |
| SMA: Bearish | Sep 27, 2021 | 5 years ago |
| SMA: Bullish | Sep 13, 2021 | 5 years ago |
| MACD: Buy Signal | Aug 16, 2021 | 5 years ago |
| SMA: Bullish | Aug 9, 2021 | 5 years ago |
| SMA: Bearish | Jul 19, 2021 | 5 years ago |
| SMA: Bullish | Jun 28, 2021 | 5 years ago |
| SMA: Bearish | May 3, 2021 | 5 years ago |
| SMA: Bullish | Apr 26, 2021 | 5 years ago |
| SMA: Bearish | Mar 29, 2021 | 5 years ago |
| SMA: Bearish | Feb 15, 2021 | 5 years ago |
| MACD: Sell Signal | Feb 15, 2021 | 5 years ago |
| SMA: Bullish | Feb 1, 2021 | 5 years ago |
| SMA: Bearish | Jan 25, 2021 | 5 years ago |
| RSI: Overbought | Oct 19, 2020 | 6 years ago |
| MACD: Buy Signal | Sep 21, 2020 | 6 years ago |
| SMA: Bullish | Sep 14, 2020 | 6 years ago |
| SMA: Bullish | Sep 7, 2020 | 6 years ago |
| SMA: Bearish | Aug 31, 2020 | 6 years ago |
| SMA: Bullish | Aug 24, 2020 | 6 years ago |
| SMA: Bearish | Jun 22, 2020 | 6 years ago |
| SMA: Bearish | Jun 22, 2020 | 6 years ago |
| SMA: Bullish | May 4, 2020 | 6 years ago |
| SMA: Bullish | Apr 6, 2020 | 6 years ago |
| SMA: Bearish | Mar 30, 2020 | 6 years ago |
| MACD: Sell Signal | Feb 17, 2020 | 6 years ago |
| SMA: Bearish | Feb 10, 2020 | 6 years ago |
| SMA: Bullish | Feb 3, 2020 | 6 years ago |
| SMA: Bearish | Jan 27, 2020 | 6 years ago |
| RSI: Overbought | Oct 14, 2019 | 7 years ago |
| RSI: Overbought | Sep 16, 2019 | 7 years ago |
| SMA: Bullish | Sep 9, 2019 | 7 years ago |
| MACD: Buy Signal | Sep 9, 2019 | 7 years ago |
| MACD: Sell Signal | Aug 19, 2019 | 7 years ago |
| SMA: Bearish | Aug 5, 2019 | 7 years ago |
| RSI: Overbought | Jul 1, 2019 | 7 years ago |
| RSI: Overbought | Jun 10, 2019 | 7 years ago |
| SMA: Bullish | May 13, 2019 | 7 years ago |
| SMA: Bullish | Apr 8, 2019 | 7 years ago |
| SMA: Bearish | Jan 21, 2019 | 7 years ago |
| SMA: Bullish | Jan 7, 2019 | 7 years ago |
| SMA: Bearish | Dec 10, 2018 | 7 years ago |
Key statistics
- Market cap
- 6.23B
- Enterprise value
- 6.22B
- Trailing P/E
- 0.00
- Forward P/E
- -28.87
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 101.83
- EPS (TTM)
- -4.19
- Beta
- 2.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -58.39M
- Total cash
- 125.90M
- Total debt
- 52.76M
- Return on equity
- -368.37%
- Shares outstanding
- 62.85M
- Short % of float
- 21.40%
- 50-day average
- 62.54
- 200-day average
- 41.74
Analyst view
Consensus: strong buy
- Target (low)
- 103.00
- Target (mean)
- 121.67
- Target (high)
- 145.00
- Strong buy1
- Buy5
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 12, 2026
Expected Nov 12, 2026. Consensus EPS estimate -1.01.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2026 | Sep 30, 2026 | -1.06 | — | — | — |
| Aug 12, 2026 | Jun 30, 2026 | -0.95647 | -1.05 | -0.09 | -9.78% |
| May 7, 2026 | Mar 31, 2026 | -0.93 | -0.94 | -0.01 | -1.08% |
| Mar 31, 2026 | Dec 31, 2025 | -1.02 | -1.04 | -0.02 | -1.96% |
| Nov 13, 2025 | Sep 30, 2025 | -1.07 | -1.16 | -0.09 | -8.41% |
| Aug 13, 2025 | Jun 30, 2025 | -1.01 | -1.03 | -0.02 | -1.98% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | HC Wainwright & Co. | main | Buy | Buy |
| Sep 28, 2026 | LifeSci Capital | main | Outperform | Outperform |
| Sep 28, 2026 | UBS | main | Buy | Buy |
| Sep 28, 2026 | HC Wainwright & Co. | main | Buy | Buy |
| Sep 17, 2026 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 17, 2026 | HC Wainwright & Co. | reit | Buy | Buy |
About Kodiak Sciences Inc.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- kodiak.com
News
- 10 Health Care Stocks Whale Activity In Today’s Session
- Can Zenkuda's Multi-Indication Potential Drive KOD Stock Higher?
- Kodiak Sciences Inc. (NASDAQ:KOD) Stock Has Average Target Price of $104.71
- 11 Stocks Most Likely to See a Short Squeeze Rally
- HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $126
- Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026
- Top 3 Health Care Stocks That May Collapse In Q4
- Kodiak Sciences' Two Wet AMD Treatments Match Aflibercept in Phase III Study
- Kodiak Sciences (NASDAQ:KOD) Director Bros. Advisors Lp Baker Acquires 33,726 Shares of Company Stock
- A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?
Your note
Sign in to keep a note on KOD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKER BROS ADVISORS L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 28, 2026 | 0 |
| BORGESON JOHN A | Chief Financial Officer | Sale | Jun 3, 2026 | 211,930 |
| PERLROTH VICTOR D | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 24, 2026 | 3,676,060 |
| YANG TAIYIN | Director | Conversion of Exercise of derivative security | Oct 22, 2026 | 20,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baker Bros. Advisors, LP | 31.69% | 19,919,186 | 1.98B | Jun 29, 2026 |
| Blackrock Inc. | 6.58% | 4,135,355 | 410.14M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.17% | 3,248,611 | 322.20M | Jun 29, 2026 |
| State Street Corporation | 3.85% | 2,419,417 | 239.96M | Jun 29, 2026 |
| Goldman Sachs Group Inc | 3.69% | 2,316,014 | 229.70M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 2.87% | 1,804,632 | 178.98M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.05% | 1,288,755 | 127.82M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.04% | 1,281,918 | 127.14M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.63% | 1,024,195 | 101.58M | Sep 29, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 1.61% | 1,013,711 | 100.54M | Jun 29, 2026 |
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 0.95% | 595,991 | 59.11M | Jun 29, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 0.94% | 590,816 | 58.60M | Jun 29, 2026 |